Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Historical Holders from Q3 2020 to Q3 2025

Symbol
RLAY on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
171,717,172
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
166,222,637
Holdings value
$867,515,589
% of all portfolios
0.002%
Number of holders
196
Number of buys
82
Number of sells
-87
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Commodore Capital LP 9.9% +26.2% $88,740,000 +$19,053,000 17,000,000 +27.3% Commodore Capital LP 30 Sep 2025
Point72 Asset Management, L.P. 7.8% +35% $50,152,476 +$13,993,047 13,445,704 +38.7% Point72 Asset Management, L.P. 30 Jun 2025
BlackRock, Inc. 6.1% -30% $32,882,558 -$13,928,338 10,308,012 -29.8% BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.47% -23.9% $32,454,284 -$9,430,469 9,379,851 -22.5% The Vanguard Group 30 Jun 2025

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 166,222,637 $867,515,589 -$18,487,292 $5.22 196
2025 Q2 170,927,354 $591,366,333 +$36,190,035 $3.46 203
2025 Q1 162,665,545 $426,190,863 -$16,276,230 $2.62 205
2024 Q4 163,889,986 $675,297,060 -$42,360,167 $4.12 197
2024 Q3 163,415,012 $1,156,675,796 +$253,277,512 $7.08 193
2024 Q2 126,697,163 $826,050,230 -$42,426,305 $6.52 171
2024 Q1 132,236,260 $1,097,561,545 +$24,572,655 $8.3 182
2023 Q4 127,244,702 $1,400,985,578 -$17,110,979 $11.01 176
2023 Q3 130,456,510 $1,097,122,997 -$2,918,566 $8.41 169
2023 Q2 129,294,786 $1,623,964,520 -$20,848,790 $12.56 159
2023 Q1 131,039,866 $2,156,444,291 +$53,163,179 $16.47 155
2022 Q4 128,192,171 $1,915,159,649 +$58,936,160 $14.94 163
2022 Q3 123,551,085 $2,763,964,560 +$25,518,843 $22.37 153
2022 Q2 120,596,011 $2,019,993,086 +$124,571,798 $16.75 137
2022 Q1 113,095,261 $3,384,210,971 +$67,735,824 $29.93 133
2021 Q4 110,982,949 $3,407,692,692 +$588,792,014 $30.71 128
2021 Q3 91,778,622 $2,894,965,132 +$74,331,777 $31.53 132
2021 Q2 89,144,608 $3,261,742,353 +$138,052,473 $36.59 124
2021 Q1 85,493,244 $2,955,555,198 -$171,240,328 $34.57 135
2020 Q4 87,701,562 $3,644,892,889 +$108,159,345 $41.56 115
2020 Q3 84,683,348 $3,603,495,710 +$3,603,495,710 $42.59 94